Cover Image

Differences in benefits of office based opioid treatment: Secondary analyses across sub‐groups in the PROUD randomized controlled implementation trial

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Katharine A. Bradley, Noorie Hyun, Abisola Idu, Onchee Yu, Jennifer F. Bobb, Paige D. Wartko, Zoe Weinstein, Abigail G. Matthews, Jennifer McCormack, Amy K. Lee, Jeffrey H. Samet
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Addiction
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Distinguishing chronic disease profiles and cause of death attribution in opioid and or stimulant toxicity deaths to inform overdose prevention efforts
by: Heather Palis, et al.
Published: (2026)

Association between change in alcohol use reported during routine healthcare screening and change in subsequent hospitalization: A retrospective cohort study
by: Helen E. Jack, et al.
Published: (2025)

Clinical factors linked to xylazine exposure in emergency department patients with illicit opioid overdose
by: Jennifer S. Love, et al.
Published: (2026)

A cost–benefit analysis of the implementation and scale‐up of harm reduction interventions in the Australian Capital Territory
by: Anna L. Bowring, et al.
Published: (2026)

Screening for addiction in the dental office: The bottom line
by: Carrigan L. Parish, et al.
Published: (2026)

Refining cause of death attribution among opioid, opioid‐stimulant and stimulant acute toxicity deaths
by: Yi‐Shin Grace Chang, et al.
Published: (2025)

Increased risk of type I errors for detecting heterogeneity of treatment effects in cluster-randomized trials using mixed-effect models
by: Hyun, Noorie, et al.
Published: (2024)

Juvenile probation officers’ lived experiences of collaboration with clinical mental health counselors: An interpretive phenomenological analysis
by: Henrietta Shannon Gantt, et al.
Published: (2024)

Assessing the acceptability of implementing a Screening, Brief Intervention and Referral to Treatment for alcohol use among transgender women in Bangkok, Thailand: A mixed‐method pre‐implementation study using the Consolidated Framework for Implementation Research
by: Pongkwan Yimsaard, et al.
Published: (2024)

The Opioid Safety Toolkit: An interactive prescription opioid safety toolkit to increase opioid safety literacy and behaviours among people prescribed opioids for pain—a randomised controlled trial
by: Suzanne Nielsen, et al.
Published: (2026)

Impact of enhanced practices on opioid overdose deaths: A community‐based modeling approach
by: Carolina Barbosa, et al.
Published: (2026)

Evaluating comparative effect of non‐pharmacological interventions adjunctive to opioid agonist therapy for opioid use disorder: A systematic review with network meta‐analysis
by: Bei Lv, et al.
Published: (2026)

Evaluating the optimal duration of medication treatment for opioid use disorder
by: Corey J. Hayes, et al.
Published: (2026)

Mapping corporate sponsorship of alcohol and gambling associations: An Australian pilot study
by: Cara Platts, et al.
Published: (2025)

Systematic review of patient‐reported outcome measures for opioid use disorder recovery
by: Jarratt D. Pytell, et al.
Published: (2025)

Predictors of emergency medical transport refusal following opioid overdose in Washington, DC
by: Ben Turley, et al.
Published: (2024)

The benefits and challenges of online player tracking
by: Paul Delfabbro
Published: (2024)

Questioning methadone split‐dosing for analgesia among hospitalized patients with opioid use disorder
by: Dale Terasaki, et al.
Published: (2024)

Impact of study design decisions on identification of treatment initiators of medications for opioid use disorder
by: Payel J. Roy, et al.
Published: (2025)

Combating opioid misuse in Nigeria: A comprehensive strategy for public health and social stability
by: Rasaq Oladapo, et al.
Published: (2024)

Retention in opioid agonist treatment during pregnancy and variations according to treatment and maternal characteristics
by: Bianca Varney, et al.
Published: (2026)

Academic detailing is effective at altering clinician practice and patient outcomes for opioid use disorder
by: Jonathan Zhang, et al.
Published: (2026)

Empirically contrasting urine drug screening‐based opioid use disorder treatment outcome definitions
by: Laura Brandt, et al.
Published: (2024)

Commentary on Stam et al .: The substantial and dynamic contribution of opioid potency to total overdose risk
by: Phillip O. Coffin
Published: (2024)

Commentary on Gregory et al .: Fear of precipitated opioid withdrawal should not prevent buprenorphine initiation
by: Sandra A. Springer
Published: (2024)

A comparative study of treatment retention in opioid use disorder: Subcutaneous injectable versus sublingual buprenorphine
by: Charles Deng, et al.
Published: (2025)

Comment on Domzaridou et al .: Recognising the complexities of co‐prescriptions and lifestyle factors in opioid agonist treatment
by: Adam Bakker, et al.
Published: (2024)

Prescribing practices in opioid agonist treatment and changes in compliance to clinical dosing guidelines in British Columbia, Canada
by: Brenda Carolina Guerra‐Alejos, et al.
Published: (2024)

Commentary on Young et al .: Clinical guidance is required for stimulant co‐prescription with opioid agonist therapy
by: Nadine Ezard, et al.
Published: (2025)

Buprenorphine‐based treatments outcomes in pregnant opioid‐dependent women: A systematic review and meta‐analysis
by: Farzad Akbarzadeh, et al.
Published: (2025)

Pain in people seeking and receiving opioid agonist treatment: A systematic review and meta‐analysis of prevalence and correlates
by: Jie Yang, et al.
Published: (2024)

The impact of opioid, cannabis and cocaine use disorder on the risk of diabetic retinopathy in patients with type 2 diabetes mellitus
by: Ming‐Pei Yueh, et al.
Published: (2025)

Dose‐specific clinical outcomes in patients with opioid use disorder treated with 24–32 mg/day of buprenorphine
by: Julia D’Agata Mount, et al.
Published: (2024)

Public perceptions of opioid misuse recovery and related resources in a nationally representative sample of United States adults
by: Olivia Golan, et al.
Published: (2024)

Relative risks of adverse effects across different opioid agonist treatments—A systematic review and meta‐analysis
by: Maximilian Meyer, et al.
Published: (2025)

Comparative effectiveness of alternative times to opioid agonist treatment taper initiation on taper completion and all‐cause mortality among people with opioid use disorder: A retrospective population‐based target trial emulation study in British Columbia, Canada, 2010–2020
by: Ruyu Yan, et al.
Published: (2026)

Commentary on Dennett et al .: When heat and the opioid epidemic collide ‐ implications for climate‐resilient public health strategies
by: Tarik Benmarhnia
Published: (2025)

Commentary on Bade et al.: Threat of nitazenes and other potent synthetic opioids—Is Europe prepared? Time to respond and to learn
by: Isabelle Giraudon, et al.
Published: (2025)

Pharmacological treatment strategies to manage precipitated withdrawal following the administration of buprenorphine in opioid use disorder: A systematic review
by: Emmert Roberts, et al.
Published: (2026)

Navigating pregnancy and addiction recovery: Patient perspectives on perinatal care interventions for women with opioid use disorder in Kentucky, USA
by: Hilary L. Surratt, et al.
Published: (2026)